Clinical Trial Update: FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating fecal microbiota transplantation for Primary Sclerosing Cholangitis; the study is currently recruiting. The trial also in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease
• Sclerosing Cholangitis

Drugs mentioned

• Fecal microbiota transplantation (fecal microbiota transplantation)

Snippet

Sponsor: University of Birmingham | Conditions: Primary Sclerosing Cholangitis, Inflammatory Bowel Diseases | Phase 2 | Status: RECRUITING